NCT02528838View on ClinicalTrials.gov

An Observational Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide.

CompletedOBSERVATIONAL
Enrollment

238

Participants

Timeline

Start Date

May 1, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

January 15, 2018

Conditions
Multiple Myeloma
Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY